The opportunities and challenges inherent in using protein biomarkers for new drug development

Eli Lilly

FDA authorizes COVID-19 antibody cocktail for younger children

Graphic representation of technology’s expanding role in clinical research from Curebase.

9 predictions for pharma in 2022


4 potential pulmonary fibrosis therapies to watch

Gilead logo

Gilead Sciences, Merck near the top of Newsweek’s most responsible companies list

FDA Acting Commissioner Dr. Janet Woodcock

FDA’s Woodcock reassures about COVID-19 tests, vaccines under Omicron


FDA advisory committee votes in favor of COVID-19 pill molnupiravir

Public Citizen

Why Public Citizen is skeptical about the COVID-19 antiviral molnupiravir

SARS-CoV-2 image

Early data suggest COVID-19 monoclonal antibodies offer less protection against Omicron variant